Comparative accuracy of bowel ultrasound versus magnetic resonance enterography in combination with colonoscopy in assessing Crohn's disease and guiding …

M Allocca, G Fiorino, C Bonifacio… - Journal of Crohn's …, 2018 - academic.oup.com
Background The comparative accuracy of bowel ultrasound [US] versus magnetic
resonance enterography [MRE] in combination with colonoscopy [CS] in assessing Crohn's …

Crohn's disease associated strictures

WPW Chan, F Mourad… - Journal of gastroenterology …, 2018 - Wiley Online Library
Crohn's disease (CD) is a chronic relapsing and remitting disease that can affect any
segments of the gastrointestinal tract. More than 50% of patients with CD develop stricturing …

Systematic review with metaanalysis: endoscopic balloon dilatation for Crohn's disease strictures

PS Morar, O Faiz, J Warusavitarne… - Alimentary …, 2015 - Wiley Online Library
Background Endoscopic balloon dilatation (EBD) is recognised treatment for symptomatic
Crohn's strictures. Several case series report its efficacy. A systematic analysis for overall …

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study

WJ Sandborn, SD Lee, D Tarabar, E Louis, M Klopocka… - Gut, 2018 - gut.bmj.com
Objective This phase II, randomised, double-blind, placebo-controlled clinical trial was
designed to evaluate the efficacy and safety of PF-00547659, a fully human monoclonal …

Crohn's disease: a clinical update

F Ha, H Khalil - Therapeutic advances in gastroenterology, 2015 - journals.sagepub.com
Crohn's disease is increasing in prevalence worldwide. It arises from a complex interplay
between both genetic predisposition and environmental influence. A search of databases …

[HTML][HTML] Fibrostenotic strictures in Crohn's disease

JH Yoo, S Holubar, F Rieder - Intestinal research, 2020 - ncbi.nlm.nih.gov
The use of biologic agents including anti-tumor necrosis factor monoclonal antibodies
followed by anti-integrins and anti-interleukins has drastically changed the treatment …

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis

RS Choung, F Princen, TP Stockfisch… - Alimentary …, 2016 - Wiley Online Library
Summary Background Patients with Crohn's disease (CD) have serologic responses to
various microbial antigens. Serologic markers are associated with aggressive forms of …

Early intervention in Crohn's disease: towards disease modification trials

S Danese, G Fiorino, L Peyrin-Biroulet - Gut, 2017 - gut.bmj.com
Crohn's disease (CD) is a chronic progressive destructive inflammatory bowel disease. As in
rheumatoid arthritis, there is increasing evidence that early treatment initiation with disease …

[HTML][HTML] Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil

JML Parente, CSR Coy, V Campelo… - World Journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To evaluate the demographic characteristics and clinical phenotypes of inflammatory
bowel disease (IBD) in a geographic area in Northeastern Brazil. METHODS: This …

Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local rho kinase inhibitor

T Holvoet, S Devriese, K Castermans, S Boland… - Gastroenterology, 2017 - Elsevier
Background Intestinal fibrosis resulting in (sub) obstruction is a common complication of
Crohn's disease (CD). Rho kinases (ROCKs) play multiple roles in TGFβ-induced …